Amphastar Pharmaceuticals, Inc. Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Amphastar Pharmaceuticals, Inc. shares issued, shares, share-based payment arrangement, before forfeiture for the quarter ending 2019-09-30 was 186.28K shares, a 8.82% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. shares issued, shares, share-based payment arrangement, before forfeiture for the quarter ending 2018-09-30 was 171.19K shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2019-09-30 | 186.28K shares 10-Q · filed 2019-11-08 | |
| 2018-09-30 | 171.19K shares 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |